A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis

This study is ongoing, but not recruiting participants.

Sponsor:

Information provided by (Responsible Party):

Hoffmann-La Roche

ClinicalTrials.gov Identifier:

NCT01194570

First received: August 28, 2010

Last updated: January 6, 2017

Last verified: January 2017

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	April 2021
Primary Completion Date:	July 2015 (Final data collection date for primary outcome measure)
Certification or Request for Extension to Delay Results Received:	October 14, 2016

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):